Goldman Sachs Asset Management to Acquire Synthon from BC Partners
Goldman Sachs Asset Management acquires Dutch generic drugmaker Synthon for €2 billion from BC Partners. This deal positions GSAM as a key player in the generics market and marks a significant return for BC Partners.
Goldman Sachs Asset Management to Acquire Synthon from BC Partners Read More »